EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition

Yasmeen El Hajj Abdallah, Sukhman Chahal, Fakhreddin Jamali, Sherif Hanafy Mahmoud

Journal of Pharmacy & Pharmaceutical Sciences · 2023

DOI: 10.3389/jpps.2023.11137 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pharmacy & Pharmaceutical Sciences, 2023. Verfasst von Yasmeen El Hajj Abdallah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada. Hauptthemen laut MEDLINE: Crohn Disease, Arthritis, Rheumatoid. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation is a culprit in many conditions affecting millions of people worldwide. A plethora of studies has revealed that inflammation and inflammatory mediators such as cytokines and chemokines are associated with altered expression and activity of various proteins such as those involved in drug metabolism, specifically cytochrome P450 enzymes (CYPs). Emphasis of most available reports is on the inflammation-induced downregulation of CYPs, subsequently an increase in their substrate concentrations, and the link between the condition and the inflammatory mediators such as interleukin-6 and tumor necrosis factor alpha. However, reports also suggest that inflammation influences expression and/or activity of other proteins such as those involved in the drug-receptor interaction. These multifaced involvements render the clinical consequence of the inflammation unexpected. Such changes are shown in many inflammatory conditions including rheumatoid arthritis, Crohn’s disease, acute respiratory illnesses as well as natural processes such as aging, among others. For example, some commonly used cardiovascular drugs lose their efficacy when patients get afflicted with inflammatory conditions such as rheumatoid arthritis and Crohn’s disease. Interestingly, this is despite increased concentration subsequent to reduced clearance. The observation is attributed to a simultaneous reduction in the expression of target receptor proteins such as the calcium and potassium channel and β-adrenergic receptor as well as the metabolic enzymes. This narrative review summarizes the current understanding and clinical implications of the inflammatory effects on both CYPs and drug-receptor target proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseArthritis, RheumatoidHumansInflammationCytokinesCytochrome P-450 Enzyme SystemInflammation Mediators

Stichwörter der Autor:innen

drug-disease interactiondrugsdrugs actiondrugs dispositioninflammation

Substanzen

CytokinesCytochrome P-450 Enzyme SystemInflammation Mediators

Autor:innen und Institutionen

  • Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.

Zitieren

APA

Abdallah, Y. E. H., Chahal, S., Jamali, F., & Mahmoud, S. H. (2023). Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition. Journal of Pharmacy & Pharmaceutical Sciences. https://doi.org/10.3389/jpps.2023.11137

Vancouver

Abdallah YEH, Chahal S, Jamali F, Mahmoud SH. Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition. Journal of Pharmacy & Pharmaceutical Sciences. 2023. doi:10.3389/jpps.2023.11137

BibTeX
@article{Abdallah2023,
  author = {Abdallah, Yasmeen El Hajj and Chahal, Sukhman and Jamali, Fakhreddin and Mahmoud, Sherif Hanafy},
  title = {Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition},
  journal = {Journal of Pharmacy & Pharmaceutical Sciences},
  year = {2023},
  doi = {10.3389/jpps.2023.11137}
}
Kostenlos starten →